Trial intelligence / Profile preview

Lidocaine Infusion for Postoperative Analgesia in Thoracoscopic Partial Lung Resection

NCT05901389Completed

Sponsor
Qilu Hospital of Shandong University
Start
Jun 2023
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Postoperative Pain Score at Day 1. Started Jun 2023; status: completed.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05901389.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05901389.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call